Why Attend
The Annual European Microbiome Congress has become a trusted learning and networking platform for leading academics, practicing clinicians, pharmaceutical and nutrition companies, biotech entrepreneurs and investors, government and regulatory bodies and industry leaders who require insight into the latest microbiome research, clinical trials and multi-disciplinary collaborations.
Join us for 2.5 days of intense networking, unpublished research and translational case studies. On the13th we have a pre-conference workshop day and the 14th-15th is the main conference.
In addition to the open networking available the dedicated poster session is a great way to get your research noticed and further involve yourself with the congress!
World Class Speaker faculty will provide key take-aways on how to implement their methods on the following areas:
-Multi-omics analysis
-Illucidating mechanisms & networks
-Systems biology approaches
What's New for 2018
Functional microbiome studies: beyond sequencing
Accelerate drug development through metabolomics & multi-omics approaches to identify novel targets
Microbial dark matter: Culturing the unculturable
Explore the methods and protocols being developed to cultivate unculturable or low abundance bacteria to provide a fuller understanding of microbial communities and networks
Bioinformatics 101
Recognise how to integrate bioinformatics into study design to maximise on research outputs
Early Life Microbiome
Determine the influence of the infant and maternal microbiomes on immune development and health outcomes
View Video from European Microbiome Congress 2016
The Speakers
Rose Szabady
Dr. Jordana T. Bell
Jordana Bell is a Senior Lecturer at King's College London. She studies the genomic basis of complex human disease in human populations, focusing on intermediate phenotypes including variation in epigenetic and microbiome profiles. In the context of human microbiome research, Jordana has contributed towards characterising host genetic and environmental influences on the gut microbiome, and understanding how variation in the microbiome relates to metabolic health.
William Wade
Magali Cordaillat-Simmons
Dr. Magali Cordaillat-Simmons earned her Ph. D. in 2005 at the Université Paris V René Descartes, France, in Cardiovascular Pharmacology where she studied the impact of high sodium intake on cardiac, vascular, and renal alterations.
She then had the opportunity to work as a research Associate at the University of Virginia, VA, USA, under the guidance of Pr. Ariel Gomez in the pediatrics department where she studied the influence of epigenetics on renin expression.
Today, Dr. Cordaillat works as the Scientific and Regulatory Affairs Director at the Pharmabiotic Research Institute (PRI), located in Narbonne, France. The PRI is a non-profit industry group dedicated to supporting companies in the development of Live Biotherapeutic Products in Europe.
There she manages the progression of the association’s European regulatory strategy regarding the evolution of the pharmaceutical legislation, the association‘s regulatory activities, the interactions with national medicines agencies, the European Medicines Agency, the European Pharmacopoeia and the European Commission.
Jean de Gunzburg
Talk to me about… your research
I am the chief scientific officer at Da Volterra, a French biotechnology company, headquartered in Paris, France. Da Volterra is committed to the discovery and development of innovative approaches to prevent the deleterious consequences of antibiotic treatments on the intestinal microbiota, including the emergence and dissemination of antimicrobial resistance, as well as the occurrence of infections by opportunistic pathogens such as Clostridium difficile. Prior to that, I led an academic career as a cell biologist focusing on signal transduction and oncogenesis, ultimately leading a research laboratory at the Institut Curie in Paris.
Talk to me about…something people may not know about you
I was born in Canada, lived for most of my life in France, and am now based in the London. I am an avid off-piste skier, in the French and Swiss Alps. I particularly enjoy the slow hiking/skinning up the mountains which gives me time to appreciate the fabulous scenery, and to think in depth about new and arising matters, in particular in relation to my research.
Cheryl Zimberlin
Wendy Russell
Lars Engstrand
Christian Roghi
Sarah Hemmasi
Marcus Claesson
Elisabeth Bik
Sebastien Guery
Ariel Cohen
Dr. Ariel Cohen is Director of Business Development and Alliances at BiomX, a microbiome drug discovery company. Prior to his role in BiomX, Dr. Cohen co-founded two biotech companies: OnTimeBio (Diagnostics) and Ensof Biosystems (Target discovery) and managed development of three academic discoveries to drug development companies. Dr. Cohen held business development roles at Integra Holdings, Yissum (Hebrew University’s Tech Transfer Office), and Aurum Ventures MKI. Prior to that Dr. Cohen served as Senior Project Manager at Evogene (NYSE:EVGN) an agriculture biotechnology company. Dr. Cohen holds a Ph.D. in Systems Biology and an M.Sc. in Computational Biology from the Weizmann Institute of Science and has published in top peer-reviewed journals, including; Science, Nature and Cell.
Mel Greaves
Professor Jeroen Raes
Jeroen Raes is group leader of the Bioinformatics and (eco-)Systems Biology (BSB) research group at VIB in Brussels. He has an extensive track record in meta-omics and microbiome research. He is associate editor for ISME journal, Scientific Reports (Nature publishing group), SIGS and Genomics Insights and is reviewer and/or committee member for ANR/NWO/FWO/ERC proposals.The Raes lab combines large-scale, next-generation sequencing with novel computational approaches to investigate the functioning and variability of the healthy human microbiome at the systems level and studies its alteration in disease.
Paul Wilmes
Sue Llewellyn
Dr. Henrik Bjørn Nielsen
Dr Morten L. Isaksen
Marcus De Goffau
Adrien Nivoliez
Dr Andrew Page
Dr. Ruairi C. Robertson
Mike Frodsham
Dr Hue-Tran Hornig-Do
Shahram Lavasani
2018 Sponsors
Zymo Research
Website: http://www.zymoresearch.com
Zymo Research is historically recognized for its innovation of high quality nucleic acid purification technologies. Under the branding DNA Purification Made Simple™ and RNA Purification Made Simple™, our technologies are pushing the limits of what is possible with nucleic acid isolation. As The Epigenetics Company™, Zymo Research has also received much attention for its rapidly expanding portfolio of epigenetics products and services. It is our objective to develop and provide the most comprehensive set of tools for DNA, RNA, and epigenetic research and analysis available today. Thousands of peer-reviewed scientific publications from researchers around the world feature our technologies. Through innovation, our scientists have made streamlined DNA methylation detection possible, pioneered the micro-elution column for DNA and RNA purification, developed the simplest and the most sophisticated methods for high-quality plasmid DNA purification, and patented the first RNA purification directly from Trizol® without phase separation among many other leading technologies in the industry.
At Zymo Research, we are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. Our products are constantly evaluated by scientists like you to help ensure their reliability and the highest standard of quality.
ProDigest
Website: http://www.prodigest.eu
ProDigest is a product leader in the development of unique laboratory models of the human and animal gastrointestinal tract (Simulator of the Human Intestinal Microbial Ecosystem - SHIME®). The use of this scientific-validated platform is supported by more than 130 A1 publications. Complementary to in vivo studies, these models allow to obtain unique insight in gut processes associated to the intestinal fate, metabolism and bioavailability of actives/ingredients and to study the complete gut microbiota under controlled conditions and its link with human and animal health. The SHIME® platform can be coupled with multiple models of cells lines to assess the modulation of the gut wall in response to a specific treatment (i.e. mechanism of action). ProDigest is globally active as a service provider for food, feed and pharmaceutical companies and since 2014 also installs its technology in selected R&D facilities around the world.
Clinical Microbiomics
Website: http://www.clinical-microbiomics.com
Clinical Microbiomics is specialized in microbiome metagenomics and innovative bioinformatics concepts. We offer end-to-end microbiome research services for clinical and pre-clinical research including DNA-extraction, library preparation, sequencing and bioinformatics. Our proprietary bioinformatics platform provides our partners with leading capabilities to analyze and interpret microbiome metagenomics data.
With our pioneering Metagenomic Species Concept (MGS) and the most extensive collection of deep-sequenced human and mouse gut samples, we capture up to 80% of the microbiome diversity, which greatly supersedes normal reference-based methods. This provides our clients with a market-leading platform for studying the microbiome in relation to health, disease and treatment interventions. In addition, it allows for diverse applications, such as biomarker and drug target discovery, disease etiology investigation and subject stratification. With our range of advanced bioinformatics tools and experience in big data integration, we are able to move from association studies to mechanistic insights on microbiome metabolism and dynamics.
Biose Industrie
Website: https://www.biose.com/en/cdmo/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
Jennewein
Website: http://jennewein-biotech.de/
Jennewein Biotechnologie GmbH is a leading company specializing in the production of rare functional monosaccharides.and oligosaccharides for nutritional, pharmaceutical, cosmetic and medical applications. The company produces rare monosaccharides such as L-Fucose and Sialic Acid. It also manufactures an extensive portfolio of HMO’s such as 2‘-Fucosyllactose, 3‘-Fucosyllactose, Lacto-N-tetraose, Lacto-N-neotetraose and acidic HMO’s like 3‘-Sialyllactose and 6‘-Sialyllactose. Jennewein’s human milk oligosaccharides are produced using the latest fermentation technology.This manufacturing process is based on scientific research and ensures a high quality and safety of the product; the oligosaccharides produced in that way are structurally and functionally identical to natural HMO’s. The process can be conducted at reasonable production cost, so that for the first time an HMO can be synthesized in such large amounts that it can be used as supplement in infant food and other food products as for example medical nutrition products or food supplements.Other possible applications are in milk drinks, juices or cereal bars. In the field of R&D the company cooperates with leading German universities and research institutes. Jennewein received in 2015 approval in the US (GRAS) and in 2017 the novel food authorization for 2‘-Fucosyllactose in the European Union. The HMO‘s produced by Jennewein are approved for kosher and halal.The product is marketed under the brand-name Mum’s Sweet Secret.
Cosmos ID
Website: http://www.cosmosid.com
CosmosID®, based in Rockville, Maryland, provides solutions unlocking the microbiome. A provider of Next-Generation Sequencing (NGS) Services and Bioinformatics Solutions, CosmosID focuses on microbiome analysis and the rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications.
Services offered by CosmosID’s CLIA certified laboratory cover the entire workflow from study design to sample collection, extraction, library preparation, NGS, data analysis and publication support.
CosmosID’s cloud-based metagenomics application offers user-friendly access to the largest databases for microbial genomics, antimicrobial resistance (AMR) and virulence (VIR) data and has been independently validated to return metagenomic analyses at strain level resolution with industry leading sensitivity and precision.
DuPont
Website: http://www.dupont.com/
DUPONT INDUSTRIAL BIOSCIENCES
DuPont Industrial Biosciences, a business unit of DowDuPont Specialty Products Division, works with customers across a wide range of industries to make products and industrial processes more efficient and sustainable. Through a unique combination biotechnology, chemistry and material science capabilities, we advance market-driven, biobased solutions to meet the needs of a growing population, while protecting our environment for future generations. For updates about how DuPont Industrial Biosciences is helping customers deliver cost-effective products with superior performance and sustainability, follow @DuPontBiobased on Twitter or visit our website at biosciences.dupont.com.
DOWDUPONT SPECIALITY PRODUCTS DIVISION
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with highly differentiated materials, ingredients and capabilities that help transform industries and everyday life. DowDuPont Specialty Products includes five technology-driven businesses: Electronic Technologies, Industrial Biosciences, Nutrition & Health, Protective Solutions and Sustainable Solutions. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver real-world products and smart solutions across multiple high-value markets. DowDuPont intends to separate the Specialty Products division into an independent, publicly traded company.
www.dow-dupont.com.
BioMe
Website: http://www.bio-me.no
Bio-Me AS is a Norwegian-based biotech company, and the culmination of 20 years research on best ways to detect various bacteria in communities. This research has led to novel, patented technologies and new approaches in bacterial analysis.
Leveraging on the vast information of gut bacteria and their function, Bio-Me's business model is built on three pillars of strength:
1. The proprietary GutCheck™
2. Unique access to 30,000+ fecal samples together with extensive patient information
3. A comprehensive database containing the output from 1 and 2 above, combined with sophisticated Machine Learning tools to discover novel connections between lifestyle, genetics and microbiome patterns.
This provides important insights to support Food and Pharma companies in creating better regimes for Personalized Nutrition and Precision Medicine, as well as offering other gut microbiome analysis services.
M2P Labs
Website: http://www.m2p-labs.com/
Based in Baesweiler, Germany (near Aachen), the company was founded in November 2005 as a spin-off of RWTH Aachen University. The company focuses on microreaction and automated solutions for screening and bioprocess development. Our commercialized products are the BioLector, the BioLector Pro, and the FlowerPlate, which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical, and pharmaceutical industries to increase the number and the information content of microbial experiments (aerobic, microaerophilic, and strictly anaerobic). It enables customers to conduct experiments with high efficiency and excellent quality in microscale at low costs. With the RoboLector, the company also enables the
automated fermentation of the whole bioprocess, with the specific integration of the BioLector tool into a liquid handling system.
Metabolon
Website: http://www.metabolon.com/
Metabolon, Inc. is the world’s leading health technology company advancing metabolomics for clinical and research uses. Its Precision Metabolomics™ is accelerating research and product development across the pharmaceutical, biotechnology, consumer products, and nutrition industries. The company was founded in 2000 and is based in Research Triangle Park, North Carolina.
Media Partners
Labiotech
Website: https://labiotech.eu/
Labiotech.eu is the leading digital media covering the European Biotech industry. Over 90,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!
Beneficial Microbes
Website: http://www.wageningenacademic.com/journals/bm/general-information
Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policy makers and regulators
Drug Target Review
Website: https://www.drugtargetreview.com/
From the industry experts and publishing team behind European Pharmaceutical Review, Drug Target Review provides a voice for the drug discovery industry, promoting the latest research and developments, funding projects, and cutting-edge technological developments.
Drug Target Review’s quarterly magazine, website and annual events programme provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. 90% of our readers would recommend Drug Target Review to a friend or colleague.
Medicon Valley Alliance
Website: http://www.mva.org
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. The +250 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Medicon valley Alliance hosts, launches and drive meetings, working groups, seminars, conferences and projects, that strengthen the collaboration, networking and knowledge-sharing in the regions life science community, create critical mass and help realizing the full potential of Medicon Valley.
pharmaphorum
Website: http://pharmaphorum.com
pharmaphorum is a content and communications company offering a unique hybrid of publisher and agency working in pharma and healthcare.
pharmaphorum.com is our own independent flagship publication. It serves over 3 million unique users annually and its news and information is widely recognised as a leading source of thought leadership and strategic content for pharmaceutical professionals all over the world.
Our innovative digital magazine Deep Dive provides cutting edge insight on pharma industry trends to an audience of 100K per issue.
Rapidmicrobiology
Website: http://www.rapidmicrobiology.com/
rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions.
Keep up-to-date with the latest microbiology news by getting our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Microbiome Times
Website: http://www.microbiometimes.com
Please visit our website for more information.Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
The Agenda
Please do download the agenda to find out more information about the Summit including the main topics of discussion for the two days and our full lineup of speakers.
What You Can Expect From The 2018 Congress:
- 200+ Academic and Industry Leaders Onsite
- 40+ Thought Leaders on the Speaker Faculty
- 50:50 Ratio of Academics-Industry
Download Agenda
Venue
ILEC Conference Centre, 47 Lillie Rd, Fulham, London SW6 1UD
Based in the heart of West London and only a short ride away from London greatest landmarks, the venue is an ideal location for UK and overseas visitors.
The ILEC and Ibis London is based in the heart of West London and only a short ride away from London greatest landmarks, the venue is an ideal location for UK and overseas visitors.
Book now:
Guests can book the best available rate by calling + 44 (0)207 666 8495 or email [email protected] quoting Kisaco Research.
Subject to availability.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Poster Presentation Submission
If you are looking to highlight your recent work to the wider microbiome community, the dedicated poster session is a great way to get your research noticed and further involve yourself with the congress. In order to present a poster, you need to be registered as a delegate. Poster space is assigned on a first come, first served basis. Your presentation will be displayed in a dedicated poster area, while presentation sessions will take place both in the breaks and alongside sessions at prescheduled times.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.